Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Bordin DS, Andreev DN, Abdulkhakov SR, Voynovan IN, Bakulin IG, Bakulina NV, Vologzhanina LG, Starostin BD, Sarsenbayeva AS, Ilchishina TA, Tarasova LV, Kononova AG, Alekseenko SA, Zaytsev OV, Dekhnich NN, Bogomolov PO, Tarasova GN, Kolokolnikova OA, Khlynov IB, Plotnikova EY, Baryshnikova NV, Livzan MA, Osipenko MF, Bakanova NV, Partsvania-Vinogradova EV, Chebotareva MV, Abdulkhakov RA, Savilova IV, Sushilova AG, Kolbasnikov SV, Khurmatullina AR, Maev IV, Tishchenko MO, Petrova RE, Morkovkina LV, Tsyganova YV, Kozlova MD, Iakovlev AA, Volkov AS, Moroz ES, Gaus OV, Alba S, Farrés O, Moreira L, Parra P, Nyssen OP, Megraud F, O'Morain C, Gisbert JP

Open source

DOI: 10.3390/antibiotics15060531
Published: 2026 May 23
Container: Antibiotics (Basel, Switzerland)
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/antibiotics15060531,
  title = {Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).},
  author = {Bordin DS and Andreev DN and Abdulkhakov SR and Voynovan IN and Bakulin IG and Bakulina NV and Vologzhanina LG and Starostin BD and Sarsenbayeva AS and Ilchishina TA and Tarasova LV and Kononova AG and Alekseenko SA and Zaytsev OV and Dekhnich NN and Bogomolov PO and Tarasova GN and Kolokolnikova OA and Khlynov IB and Plotnikova EY and Baryshnikova NV and Livzan MA and Osipenko MF and Bakanova NV and Partsvania-Vinogradova EV and Chebotareva MV and Abdulkhakov RA and Savilova IV and Sushilova AG and Kolbasnikov SV and Khurmatullina AR and Maev IV and Tishchenko MO and Petrova RE and Morkovkina LV and Tsyganova YV and Kozlova MD and Iakovlev AA and Volkov AS and Moroz ES and Gaus OV and Alba S and Farrés O and Moreira L and Parra P and Nyssen OP and Megraud F and O'Morain C and Gisbert JP},
  year = {2026},
  journal = {Antibiotics (Basel, Switzerland)},
  doi = {10.3390/antibiotics15060531},
  url = {https://doi.org/10.3390/antibiotics15060531}
}

RIS

TY  - JOUR
TI  - Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
AU  - Bordin DS
AU  - Andreev DN
AU  - Abdulkhakov SR
AU  - Voynovan IN
AU  - Bakulin IG
AU  - Bakulina NV
AU  - Vologzhanina LG
AU  - Starostin BD
AU  - Sarsenbayeva AS
AU  - Ilchishina TA
AU  - Tarasova LV
AU  - Kononova AG
AU  - Alekseenko SA
AU  - Zaytsev OV
AU  - Dekhnich NN
AU  - Bogomolov PO
AU  - Tarasova GN
AU  - Kolokolnikova OA
AU  - Khlynov IB
AU  - Plotnikova EY
AU  - Baryshnikova NV
AU  - Livzan MA
AU  - Osipenko MF
AU  - Bakanova NV
AU  - Partsvania-Vinogradova EV
AU  - Chebotareva MV
AU  - Abdulkhakov RA
AU  - Savilova IV
AU  - Sushilova AG
AU  - Kolbasnikov SV
AU  - Khurmatullina AR
AU  - Maev IV
AU  - Tishchenko MO
AU  - Petrova RE
AU  - Morkovkina LV
AU  - Tsyganova YV
AU  - Kozlova MD
AU  - Iakovlev AA
AU  - Volkov AS
AU  - Moroz ES
AU  - Gaus OV
AU  - Alba S
AU  - Farrés O
AU  - Moreira L
AU  - Parra P
AU  - Nyssen OP
AU  - Megraud F
AU  - O'Morain C
AU  - Gisbert JP
PY  - 2026
JO  - Antibiotics (Basel, Switzerland)
DO  - 10.3390/antibiotics15060531
UR  - https://doi.org/10.3390/antibiotics15060531
ER  -

APA

DS, B., DN, A., SR, A., IN, V., IG, B., NV, B., LG, V., BD, S., AS, S., TA, I., LV, T., AG, K., SA, A., OV, Z., NN, D., PO, B., GN, T., OA, K., IB, K., EY, P., NV, B., MA, L., MF, O., NV, B., EV, P., MV, C., RA, A., IV, S., AG, S., SV, K., AR, K., IV, M., MO, T., RE, P., LV, M., YV, T., MD, K., AA, I., AS, V., ES, M., OV, G., S, A., O, F., L, M., P, P., OP, N., F, M., C, O., & JP, G. (2026). Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).. Antibiotics (Basel, Switzerland). https://doi.org/10.3390/antibiotics15060531

Source records

pubmed · retrieved 2026-09-25T23:49:01.684Z
doaj · retrieved 2026-09-25T23:49:01.702Z